ALKEM.NS
ALKEM.NS
INE540L01014
ALKEM LABORATORIES LTD.
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 80/100, minimal insolvency risk). The high overall score (6/7) is driven primarily by extreme stock price swings (±23.2% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
6/7 High
6 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.3x).

Beta (Market Relation)
0.29x
Defensive
Volatility (5Y p.a.)
23.2% p.a.
5-Year Horizon
Max Drawdown (5Y)
-28.3%
5-Year Horizon
Sharpe Ratio
0.15
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -4.4%
3 Years 24.1% -28.3% 0.47 +13.9%
5 Years 23.2% -28.3% 0.15 +5.9%
10 Years 24.9% -28.3% 0.38 +12%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
ende